Ultragenyx
Ultragenyx

Ultragenyx

Measured by AhrefsDR67Ahrefs DR: 67/100. Above median. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent50Agent Readiness: 50/100. Top 25%. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed58Site Speed: 58/100. Below median. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust82Data Trust: 82/100. Top 25%. Measured by StartupHub.ai. Median 61.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

2010Active1,498Novato, United States

About

Ultragenyx is a biopharmaceutical company dedicated to developing and delivering transformative treatments for rare and ultrarare genetic diseases where no current options exist. They explore various drug modalities to create the best treatment strategy for each genetic disease they study, serving patients globally. The company is committed to advancing innovative medicines and has a robust pipeline of therapies in development.

Key facts

Website
ultragenyx.com
Headquarters
Novato, United States
Founded
2010
Employees
1,498
Business model
B2B

Tech stack

Detected on ultragenyx.com, last scanned 7 Nov 2026.

Frontend
Tailwind CSS
CDN
Cloudflare
Email provider
Mimecast
Email marketing
Salesforce Pardot

Test your Ahrefs DR

The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.

Write the first review

Frequently asked

Is Ultragenyx trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Ultragenyx is 82 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How many employees does Ultragenyx have?

Ultragenyx has approximately 1,498 people on record.

SEC filings, insider activity, nonprofit links and pay benchmarks for Ultragenyx:

Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules